APO 095
Pill imprint APO 095 has been identified as Doxazosin mesylate 4 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.
Doxazosin 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxazosin mesylate Images
- Imprint:
-
APO
095 - Strength:
- 4 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0095
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-5524 | Major Pharmaceuticals |
| 54569-5170 | A S Medication Solutions LLC (repackager) |
| 54868-4802 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Doxazosin Mesylate resources
- Doxazosin
- Doxazosin (Wolters Kluwer)
- Doxazosin Extended-Release Tablets (Wolters Kluwer)
- doxazosin (Cerner Multum)
- doxazosin (Micromedex) - Includes Dosage Information
- Doxazosin Mesylate (AHFS DI)
- Doxazosin (FDA)
- Doxazosin Mesylate (Wolters Kluwer)
Search Again
